SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (84)2/14/2000 8:52:00 PM
From: Miljenko Zuanic  Read Replies (1) of 447
 
<<Can't believe that I've won on both sides of the old battle, Sibia versus KDUS, and that I'm winning now that the Cadus assets have been purchased. Three for three, and all because I had a few beers with you.>>

Now, I am realising that KDUS assets are much more than I ever thought.

Thanks for help on this from KDUS analysis.

Adenosine receptors are again *HOT*. This is new opportunity for OSIP. I have to give credit C. Goddard on this one.

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News